ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1539

Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease

Monica Yang1, Seoyeon Lee2, Jessica Neely3, Marina Sirota2 and Paul Wolters2, 1UCSF, SF, CA, 2UCSF, SF, 3UCSF Benioff Children's Hospital, San Francisco, CA

Meeting: ACR Convergence 2022

Keywords: Aging, genomics, interstitial lung disease, Scleroderma

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Clinical Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease characterized by diffuse fibrosis and vasculopathy that has potential to affect nearly every organ system. Interstitial lung disease (ILD) is present in up to 90% of SSc patients and the leading cause of SSc-related mortality. Difficulty in managing SSc-ILD stems from the limited understanding of the molecular mechanisms underpinning the disease. Previous work from our lab suggests a subset of SSc-ILD patients are characterized by shortened telomeres and increased expression of markers of cellular senescence (p16 and p21). Here we present a comprehensive gene expression meta-analysis in SSc-ILD lung tissues and healthy controls to identify pathologic genes and pathways, while specifically probing aging and cellular senescence pathways.

Methods: Three publicly available gene expression microarray data sets of the lung including 42 SSc-ILD subjects and 18 healthy controls were identified from the Gene Expression Omnibus (GEO). A meta-analysis was performed by first processing each data set individually according to their unique platform then cross platform normalization and data set merging to create a gene expression matrix using ComBat. Single-gene and network analyses using LIMMA, ClusterProfiler and GSEA were conducted to identify genes and pathways significantly associated with SSc-ILD. Enrichment of previously established aging and cell specific senescence signatures was assessed using hypergeometric testing.

Results: There were 586 differentially expressed genes (DEGs) (FC >1.3, q< 0.05) and 89 relevant profibrotic and non-fibrotic pathways in SSc-ILD (q< 0.05). Among the top upregulated DEGs, notable markers included MMP7, a metalloproteinase involved in extracellular matrix (ECM) degradation and biomarker of pulmonary fibrosis, KRT17, an epithelial basal cell marker overexpressed in idiopathic pulmonary fibrosis, and GDF15, a marker of cellular stress and senescence. Using hierarchical clustering based on the top 250 DEGs, 4 distinct clusters of genes emerged with pathway analysis of individual clusters demonstrating notable down regulation of cell processes and up regulation of ECM formation and collagen organization (Fig 1a). In gene set enrichment analysis, p53 and epithelial mesenchymal transition (EMT) pathways were the most highly enriched in SSc-ILD (Fig 1b). The p53 signaling pathway is hypothesized to promote lung fibrosis through apoptosis, DNA damage, and oxidative stress of lung epithelia and is also upregulated in IPF. When probing senescence signatures, we found a clear separation based on hierarchical clustering between SSc-ILD and controls (Fig 1c) and an average 2-fold enrichment of these signatures in SSc-ILD compared to all other DEGs (p< 0.05) (Fig 1d).

Conclusion: While there is a diversity of DEGs in SSc-ILD, there is a striking enrichment of aging and cellular senescence related pathways including p53 signaling pathways and epithelial and fibroblast senescence signatures. These findings demonstrate the prominent presence of cellular senescence in SSc-ILD and suggest it may be a mechanistic driver of disease pathogenesis.

Supporting image 1


Disclosures: M. Yang, None; S. Lee, None; J. Neely, None; M. Sirota, None; P. Wolters, None.

To cite this abstract in AMA style:

Yang M, Lee S, Neely J, Sirota M, Wolters P. Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/gene-expression-meta-analysis-reveals-aging-and-cellular-senescence-signatures-in-scleroderma-associated-interstitial-lung-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gene-expression-meta-analysis-reveals-aging-and-cellular-senescence-signatures-in-scleroderma-associated-interstitial-lung-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology